SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-14-180397
Filing Date
2014-05-02
Accepted
2014-05-02 17:18:10
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B4 d615506d424b4.htm 424B4 1750105
2 GRAPHIC g615506g06w83.jpg GRAPHIC 34555
3 GRAPHIC g615506g23p53.jpg GRAPHIC 24046
4 GRAPHIC g615506g30y07.jpg GRAPHIC 39636
5 GRAPHIC g615506g54q25.jpg GRAPHIC 25384
6 GRAPHIC g615506g57i48.jpg GRAPHIC 22171
7 GRAPHIC g615506g65j18.jpg GRAPHIC 47242
  Complete submission text file 0001193125-14-180397.txt   2018125
Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 617-513-9882
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-193204 | Film No.: 14810489
SIC: 2834 Pharmaceutical Preparations